AVD at a glance
AMERICAN VANGUARD CORP (AVD, SEC CIK 5981) filed its latest 10-K annual report on March 16, 2026, a 10-Q quarterly report on August 10, 2026, an 8-K current report on October 1, 2026 and Form 4 insider filings as recently as August 20, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), AMERICAN VANGUARD CORP (AVD) reported revenue of $515.1 million (down 5.9% from FY2024) and a net loss of $49.9 million. Diluted EPS was -$1.75.
- As of June 30, 2026, 23 institutional investment managers tracked by SignalX reported holding AMERICAN VANGUARD CORP (AVD) shares worth $17.6 million in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by ROSENBLOOM KEITH M on August 18, 2026 of 556,580 shares at $2.20 per share.
- In the last 90 days, AVD insiders reported 1 open-market purchase ($40K) and 1 open-market sale ($1.2M) on Form 4, a net sale of $1.2M.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $515.1M
- −5.9% vs prior year
- Insiders · 90 days
- 1 buy · 1 sell
- Net −$1.2M
- 13F holders
- 23 funds
- $17.6M · +0 vs prior quarter
- Latest 8-K
- Oct 1, 2026
- Item 7.01 · Item 5.02
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jun 30, 2026
Management Discussion & Analysis
- No profitability percentages, margins, or earnings figures provided
- Headwinds: demand, weather, geopolitics, regulation, competition, foreign exchange, supply constraints, interest rates, and inflation
Risk Factors
- New geopolitical risk: US–Iran war and Strait of Hormuz blockade disrupting oil and fertilizer shipping
- New cybersecurity risk: Agentic AI potentially outpacing existing defense tools
- New operational risk: Hannibal and Axis factories dependent on competitors for utilities and waste treatment
- Regulatory and financial constraint: First Lien Term Loan restricts stock repurchases
- Market risk: Higher grower costs could reduce demand for Company products
AI summary of the AVD 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 7.01: Regulation FD Disclosure
- Exhibit 99.1 furnished under Regulation FD, not deemed filed under Exchange Act Section 18
- Disclosure excluded from automatic incorporation into other Securities Act or Exchange Act filings
Item EX-99.1: Item EX-99.1
- Matt Horwath becomes CFO October 1, 2026, replacing David Johnson in a planned leadership transition
- David Johnson remains Chief Accounting Officer through March 2027, then non-executive employment through September 2027
Item 5.02: Departure/Appointment of Directors or Principal Officers
- Matthew Horwath appointed CFO effective October 1, 2026, bringing FARO finance, M&A, capital markets, and reporting experience
- CFO compensation: $450,000 base salary, 60% bonus target, plus $6,667 monthly relocation and $10,000 monthly travel allowances
Item 2.02: Results of Operations and Financial Condition
- Unaudited results cover three and six months ended June 30, 2026
- Press release issued August 10, 2026
Item 7.01: Regulation FD Disclosure
- Earnings call covered unaudited three- and six-month results ended June 30, 2026
- Transcript attached as Exhibit 99.2, providing management commentary and investor-relevant context
Item EX-99.1: Item EX-99.1
- Q2 sales fell 10% to $116.8 million, with international sales down 18% and U.S. crop sales down 9%
- Q2 net loss widened to $9.9 million from $849 thousand, while adjusted EBITDA declined to $6.6 million from $11.0 million
Item 5.02: Departure/Appointment of Directors or Principal Officers
- Four named executives received $450K total in success bonuses for restructuring the company’s borrowed debt
- Douglas Kaye received $150K, the largest individual award
Item 5.07: Submission of Matters to a Vote of Security Holders
- All seven director nominees re-elected, preserving board continuity
- Deloitte ratified as independent auditor with 20,904,030 votes for
Item 8.01: Other Events
- 2026 annual meeting voting results disclosed under Item 8.01
- Exhibit 99.1 contains the complete results and any implications for board proposals or shareholder matters
AI summaries of AVD 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for AVD
Don't miss the next AVD filing
- Alerts as it files. A push when AVD files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut AVD, by share count.
- Ask anything. An AI agent that reads every AVD filing and answers with sources.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| ROSENBLOOM KEITH M | Sell | Aug 18, 2026 | 556,580 | $2.20 |
| Macicek Steven D | Buy | Aug 17, 2026 | 19,000 | $2.09 |
| Kaye Douglas | J | Jul 10, 2026 | 6,527 | $2.36 |
| Gottschalk Patrick E | A | Jun 4, 2026 | 31,872 | - |
| Angelini Marisol | A | Jun 4, 2026 | 31,872 | - |
| Bassett Mark R | A | Jun 4, 2026 | 31,872 | - |
| McDougal Rubin J | A | Jun 4, 2026 | 31,872 | - |
| Macicek Steven D | A | Jun 4, 2026 | 31,872 | - |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $547.3M | $515.1M |
| Gross Profit | $179.2M | $120.3M | $147.6M |
| Operating Income | - | -$101.6M | -$28.3M |
| Net Income | $7.5M | -$126.3M | -$49.9M |
| Gross Margin | - | 22.0% | 28.6% |
| Op. Margin | - | -18.6% | -5.5% |
| Net Margin | - | -23.1% | -9.7% |
| Balance Sheet | |||
| Total Assets | $767.5M | $636.7M | $596.5M |
| Equity | - | $233.1M | $192.4M |
| ROE | - | -54.2% | -25.9% |
| Per Share | |||
| EPS | $0.26 | $-4.50 | $-1.75 |
| Cash Flow | |||
| Operating CF | - | $3.9M | -$21.2M |
Source: XBRL data in AMERICAN VANGUARD CORP (AVD)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate AVD share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 23 | $17.6M |
| Q1 2026 | 23 | $22.0M |
| Q4 2025 | 23 | $32.4M |
| Q3 2025 | 23 | $50.8M |
| Q2 2025 | 25 | $35.6M |
| Q1 2025 | 22 | $33.6M |
| Q4 2024 | 17 | $30.4M |
| Q3 2024 | 13 | $23.1M |
- AQR Capital Management+205.3K (+123%)
- Renaissance Technologies LLC+137.0K (+63%)
- FMR LLC (Fidelity)+24.3K (+9%)
- Vanguard Capital Management LLC+7.3K (+1%)
- PNC Financial Services+86 (+176%)
- BlackRock−1.15M (-55%)
- State Street Corp−503.2K (-79%)
- JPMorgan Chase & Co−345.7K (-65%)
- Morgan Stanley−336.3K (-62%)
- Dimensional Fund Advisors−270.2K (-26%)
- Millennium Management+202.5K
- Citadel Advisors LLC+42.3K
- StoneX Group Inc.+12.5K
- Vanguard Portfolio Management LLC−224.8K
- BNY Mellon−83.4K
- Fifth Third Bancorp−335
Source: 13F-HR filings on SEC EDGAR (aggregated from 169 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
AVD filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 8-K | Oct 1, 2026 | - | Analysis | - |
| 4 | Aug 20, 2026 | - | - | - |
| 4 | Aug 18, 2026 | - | - | - |
| 8-K | Aug 11, 2026 | - | Analysis | - |
| 10-Q | Aug 10, 2026 | Jun 30, 2026 | Analysis | |
| 4 | Jul 14, 2026 | - | - | - |
| 4 | Jun 9, 2026 | - | - | |
| 4 | Jun 8, 2026 | - | - | |
| 4 | Jun 8, 2026 | - | - | |
| 4 | Jun 8, 2026 | - | - | |
| 4 | Jun 8, 2026 | - | - | |
| 8-K | Jun 8, 2026 | - | Analysis | |
| 4 | Jun 5, 2026 | - | - | |
| 4 | Jun 5, 2026 | - | - | |
| 4 | Jun 5, 2026 | - | - | |
| 4 | Jun 5, 2026 | - | - | |
| 4 | Jun 5, 2026 | - | - | |
| 4 | Jun 5, 2026 | - | - | |
| 4 | Jun 5, 2026 | - | - | |
| 4 | Jun 5, 2026 | - | - | |
| 4 | Jun 4, 2026 | - | - | |
| 4 | May 19, 2026 | - | - | |
| 10-Q | May 6, 2026 | Mar 31, 2026 | Analysis | |
| 8-K | Apr 15, 2026 | - | Analysis | - |
| 8-K | Mar 19, 2026 | - | Analysis | - |
Related Health Care companies
- TXG · 10x Genomics, Inc.Laboratory Analytical Instruments
- FDMT · 4D Molecular Therapeutics, Inc.Biological Products, (No Diagnostic Substances)
- AARD · Aardvark Therapeutics, Inc.Pharmaceutical Preparations
- ABT · Abbott LaboratoriesPharmaceutical Preparations
- ABBV · AbbVie IncPharmaceutical Preparations
- ABEO · ABEONA THERAPEUTICS INC.Pharmaceutical Preparations
- ABSI · Absci CorpServices-Commercial Physical & Biological Research
- ACHC · Acadia Healthcare Company IncServices-Specialty Outpatient Facilities, NEC
AVD SEC filings: frequently asked questions
Are AVD insiders buying or selling?
In the last 90 days, AMERICAN VANGUARD CORP (AVD) officers, directors and 10% owners reported 1 open-market purchase worth $39,710 by 1 insider and 1 open-market sale worth $1.2 million by 1 insider on Form 4, a net sale of $1.2 million. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold AVD stock?
As of June 30, 2026, the largest AMERICAN VANGUARD CORP (AVD) holders among the 13F filers tracked by SignalX were Vanguard Capital Management LLC ($3.2 million), BlackRock ($2.6 million), Dimensional Fund Advisors ($2.2 million), Two Sigma Investments ($2.1 million), D.E. Shaw & Co ($1.5 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was AVD's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), AMERICAN VANGUARD CORP (AVD) reported revenue of $515.1 million (down 5.9% from FY2024) and a net loss of $49.9 million. Diluted EPS was -$1.75. The figures come from the XBRL data in the 10-K.
What did AVD report in its latest 8-K?
AMERICAN VANGUARD CORP (AVD) filed an 8-K on October 1, 2026 reporting Item 7.01 (Regulation FD Disclosure) and Item 5.02 (Departure/Appointment of Directors or Principal Officers). Exhibit 99.1 furnished under Regulation FD, not deemed filed under Exchange Act Section 18.
What are the latest AVD SEC filings?
AMERICAN VANGUARD CORP (AVD) filed its latest 10-K annual report on March 16, 2026, a 10-Q quarterly report on August 10, 2026, an 8-K current report on October 1, 2026 and a Form 4 insider filing on August 20, 2026.
What is AVD's SEC CIK number?
AMERICAN VANGUARD CORP (AVD)'s SEC Central Index Key (CIK) is 5981. EDGAR lists every AVD filing under that number.
Ask anything about AVD
The research agent reads AVD's filings, financials, insider trades and 13F holders, then answers with sources.